CTI BioPharma Gross Profit 2006-2019 | CTIC

CTI BioPharma gross profit from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
CTI BioPharma Annual Gross Profit
(Millions of US $)
2018 $25
2017 $25
2016 $56
2015 $14
2014 $59
2013 $35
2012 $
2011 $
2010 $0
2009 $0
2008 $8
2007 $0
2006 $0
2005 $16
CTI BioPharma Quarterly Gross Profit
(Millions of US $)
Q3 2019 $2
Q2 2019 $0
Q1 2019 $1
Q4 2018 $14
Q3 2018 $1
Q2 2018 $1
Q1 2018 $11
Q4 2017 $0
Q3 2017 $2
Q2 2017 $22
Q1 2017 $1
Q4 2016 $8
Q3 2016 $4
Q2 2016 $7
Q1 2016 $36
Q4 2015 $11
Q3 2015 $0
Q2 2015 $1
Q1 2015 $3
Q4 2014 $17
Q3 2014 $39
Q2 2014 $1
Q1 2014 $1
Q4 2013 $33
Q3 2013 $0
Q2 2013 $0
Q1 2013 $1
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010 $0
Q3 2010
Q2 2010 $0
Q1 2010 $0
Q4 2009 $0
Q3 2009 $0
Q2 2009 $0
Q1 2009 $0
Q4 2008 $2
Q3 2008 $2
Q2 2008 $2
Q1 2008 $3
Q4 2007 $0
Q3 2007 $0
Q2 2007 $0
Q1 2007 $0
Q4 2006 $0
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Q4 2005 $1
Q3 2005 $1
Q2 2005 $7
Q1 2005 $6
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.042B $0.026B
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its late-stage development pipeline, including pacritinib. CTI BioPharma Corp., formerly known as Cell Therapeutics, Inc., is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $64.930B 10.26
Zoetis (ZTS) United States $57.313B 34.28
Astellas Pharma (ALPMY) Japan $31.713B 15.84
Eisai (ESALY) Japan $20.263B 39.07
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $15.483B 21.13
Grifols, S.A (GRFS) Spain $15.250B 19.46
Neurocrine Biosciences (NBIX) United States $10.382B 490.13
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.043B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.171B 16.55
Jazz Pharmaceuticals (JAZZ) Ireland $7.858B 10.04
Sage Therapeutics (SAGE) United States $7.667B 0.00
Catalent (CTLT) United States $7.478B 30.42
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.014B 18.02
Arrowhead Pharmaceuticals (ARWR) United States $4.788B 109.78
United Therapeutics (UTHR) United States $4.060B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.428B 12.53
FibroGen (FGEN) United States $3.285B 96.54
Nektar Therapeutics (NKTR) United States $3.221B 0.00
Evotec AG (EVTCY) Germany $3.079B 50.38
PTC Therapeutics (PTCT) United States $2.766B 0.00
Portola Pharmaceuticals (PTLA) United States $2.270B 0.00
Xencor (XNCR) United States $2.140B 65.05
Heron Therapeutics (HRTX) United States $2.089B 0.00
Zogenix (ZGNX) United States $2.022B 0.00
Tilray (TLRY) Canada $2.003B 0.00
Corcept Therapeutics (CORT) United States $1.938B 23.56
Ironwood Pharmaceuticals (IRWD) United States $1.803B 57.50
Pacira Pharmaceuticals (PCRX) United States $1.791B 52.99
USANA Health Sciences (USNA) United States $1.568B 16.73
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.238B 20.42
Radius Health (RDUS) United States $1.135B 0.00
ArQule (ARQL) United States $1.021B 0.00
Endo (ENDP) Ireland $1.009B 1.85
Theravance Biopharma (TBPH) Cayman Islands $0.991B 0.00
Karyopharm Therapeutics (KPTI) United States $0.980B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.949B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.909B 6.20
Aerie Pharmaceuticals (AERI) United States $0.874B 0.00
Organogenesis Holdings (ORGO) United States $0.754B 0.00
TherapeuticsMD (TXMD) United States $0.702B 0.00
Translate Bio (TBIO) United States $0.639B 0.00
Collegium Pharmaceutical (COLL) United States $0.638B 0.00
Flexion Therapeutics (FLXN) United States $0.628B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ImmunoGen (IMGN) United States $0.521B 0.00
ChemoCentryx (CCXI) United States $0.505B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.465B 56.38
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.449B 0.00
Ardelyx (ARDX) United States $0.445B 0.00
OptiNose (OPTN) United States $0.440B 0.00
Dermira (DERM) United States $0.439B 0.00
Siga Technologies (SIGA) United States $0.412B 9.41
BioSpecifics Technologies Corp (BSTC) United States $0.394B 16.98
Recro Pharma (REPH) United States $0.383B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.380B 0.00
Akebia Therapeutics (AKBA) United States $0.378B 0.00
Lannett Co Inc (LCI) United States $0.363B 4.23
Harpoon Therapeutics (HARP) United States $0.360B 0.00
DURECT (DRRX) United States $0.360B 0.00
Indivior (INVVY) United States $0.355B 1.28
Innate Pharma SA (IPHYF) France $0.340B 0.00
Molecular Templates (MTEM) United States $0.300B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.287B 0.00
Rafael Holdings (RFL) United States $0.282B 0.00
GlycoMimetics (GLYC) United States $0.264B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.224B 0.00
Xeris Pharmaceuticals (XERS) United States $0.216B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.208B 0.00
Calithera Biosciences (CALA) United States $0.208B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.207B 0.00
KalVista Pharmaceuticals (KALV) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.50
Avadel Pharmaceuticals (AVDL) Ireland $0.180B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 2.28
Concert Pharmaceuticals (CNCE) United States $0.162B 0.00
Taiwan Liposome (TLC) Taiwan $0.162B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.158B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
Aquestive Therapeutics (AQST) United States $0.136B 0.00
Ocular Therapeutix (OCUL) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.132B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.130B 0.00
MEI Pharma (MEIP) United States $0.130B 0.00
CV Sciences (CVSI) United States $0.122B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
IMV INC (IMV) Canada $0.116B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.090B 0.00
MediWound (MDWD) Israel $0.085B 0.00
Majesco Entertainment (PTE) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 22.41
Otonomy (OTIC) United States $0.074B 0.00
Aclaris Therapeutics (ACRS) United States $0.073B 0.00
Pharmaxis (PXSLY) Australia $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.064B 0.00
Generex Biotechnology (GNBT) United States $0.062B 0.00
Infinity Pharmaceuticals (INFI) United States $0.060B 0.00
Champions Oncology (CSBR) United States $0.060B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.059B 14.59
Genocea Biosciences (GNCA) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
Novan (NOVN) United States $0.053B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Nivalis Therapeutics (ALPN) United States $0.048B 0.00
Capnia (SLNO) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
Bio-Path Holdings (BPTH) United States $0.028B 0.00
IsoRay (ISR) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
PharmAthene (ALT) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Melinta Therapeutics (MLNT) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Flex Pharma (SLRX) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Lipocine (LPCN) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.001B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00